Navigation Links
Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS
Date:12/1/2009

e chance of passing HIV to your baby -- High blood sugar, diabetes or worsening of diabetes, and increased bleeding in people with hemophilia have been reported in patients taking protease inhibitor medicines, including PREZISTA -- Changes in body fat have been seen in some patients taking HIV medicines, including PREZISTA. The cause and long-term health effects of these conditions are not known at this time -- As with other protease inhibitors, taking PREZISTA may strengthen the body's immune response, enabling it to begin to fight infections that have been hidden. Patients may experience signs and symptoms of inflammation that can include swelling, tenderness, or redness -- The most common side effects related to taking PREZISTA include diarrhea, nausea, headache, and abdominal pain. Uncommon but severe side effects such as inflammation of the pancreas and increased blood fat levels have also been rarely reported. This is not a complete list of all possible side effects. If you experience these or other symptoms, talk to your healthcare professional. Do not stop taking PREZISTA or any other medicines without first talking to your healthcare professional -- You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088 -- Please refer to the ritonavir (Norvir(R)) Product Information (PI and PPI) for additional information on precautionary measures

This is not a complete list of all adverse drug reactions reported with the use of PREZISTA®. Please see full Prescribing Information for more details. Full prescribing information is also available at www.PREZISTA.com.

About Tibotec Therapeutics

Tibotec Therapeutics, a division of Centocor Ortho Biotech Products, L.P., headquartered in Bridgewater, N.J., is dedicated to delivering innovative virology therapeutics that help healthcare professionals
'/>"/>

SOURCE Tibotec Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. AHF Criticizes Tibotec Over Steep Price for Newest AIDS Drug, Etravirine
2. Tibotec Conducts Two Pivotal Phase III Clinical Trials Studying TMC278 in Treatment-Naive Adults with HIV
3. Ninety-Six Week Data on Tibotec Investigational NNRTI, TMC278, Presented at AIDS 2008
4. Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008
5. Tibotec Data Presented at ICAAC and HIV9 Follow Key Regulatory Approvals for Anti-HIV Compounds
6. Tibotec Pharmaceuticals Announces Agreement to Develop and Commercialize a New Fixed-Dose Combination of TMC278 and Truvada(R) With Gilead Sciences
7. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
8. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
11. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... 2014  CVS Health is thanking its 26,000 pharmacists ... changing the way health care is delivered to increase ... retail pharmacies, mail service pharmacies and specialty pharmacies nationwide.  ... name to CVS Health to reflect our broader health ... needed to shape the future of health," said ...
(Date:9/30/2014)... - Protecting the health and safety of Canadians is our government,s ... powers and tools at its disposal to help ensure that the ... To that end, Health Canada ... Canada of all drug products from three plants ... , Apotex Pharmachem India Pvt Ltd , Apotex Research ...
(Date:9/30/2014)... BEDFORD, Mass. , Sept. 30, 2014  Hologic, ... Stephen MacMillan , Hologic,s President and Chief Executive ... Bell Ceremony on October 1, the first day of ... will discuss the Company,s campaign focused on the important ... system approved by the FDA as clinically superior to ...
Breaking Medicine Technology:CVS Health Thanking its Pharmacists during American Pharmacists Month for Helping People on Their Path to Better Health 2CVS Health Thanking its Pharmacists during American Pharmacists Month for Helping People on Their Path to Better Health 3Statement by the Honourable Rona Ambrose on the import ban of drug products from three plants in India 2Hologic to Kick Off National Breast Cancer Awareness Month at the October 1 NASDAQ Stock Market Opening Bell Ceremony 2Hologic to Kick Off National Breast Cancer Awareness Month at the October 1 NASDAQ Stock Market Opening Bell Ceremony 3
... , Knights of Columbus partners with Medishare to provide physical therapy and prosthetic limbs ... WASHINGTON , Aug. 4 ... aid of every Haitian child who lost a limb in the January earthquake that ... Many thousands more were seriously injured, including hundreds of children who lost arms and ...
... OvaGene Oncology Inc., a biotechnology ... DNA-based diagnostics for gynecologic cancer, is pleased to announce ... the Industry Collaboration Team (ICT) program.  By becoming a ... to building a strong partnership with the GOG research ...
Cached Medicine Technology:New Program Makes Prosthetics Available to All Haitian Children Who Lost Limbs in Earthquake 2OvaGene Oncology Joins The Gynecologic Oncology Group (GOG) Industry Collaboration Team to Advance Gynecologic Cancer Research 2OvaGene Oncology Joins The Gynecologic Oncology Group (GOG) Industry Collaboration Team to Advance Gynecologic Cancer Research 3
(Date:10/1/2014)... Familylifeinsurancequotes.org has released a new blog ... citizens. , Senior citizens can qualify for affordable ... to seniors who are over 50 years old. Some ... a medical examination. , Term life insurance with a ... can qualify. Having life insurance during retirement is important ...
(Date:10/1/2014)... 2014 Bedros Keuilian is not only ... fitness boot camps, he’s also considered the leading expert ... sold out business summits, a line of high-demand fitness ... a recent Spike TV reality show to his name. ... the time for personal trainers and fitness business owners ...
(Date:10/1/2014)... October 01, 2014 Phoseon Technology, the ... continues to expand the business worldwide. This rapid growth ... additional capacity for manufacturing efforts. The company has experienced ... five years and expects this growth to continue in ... technology gains worldwide adoption. , “We are very ...
(Date:10/1/2014)... Join the more than 80 golfers who already ... ever charity golf tournament to benefit Project HEAL, a not-for-profit ... cannot afford treatment. The tournament will be held Monday, Oct. ... , The day-long event starts with 10:30 a.m. check-in and ... will begin at 5 p.m. and will include an auction ...
(Date:10/1/2014)... Between 23 million and 50 million ... to figures from the National Institutes of Health (NIH) ... many of them have something else in common: They ... disease. Gluten Free Therapeutics, makers of CeliVites ... disease by publishing a series of blog posts aimed ...
Breaking Medicine News(10 mins):Health News:Affordable Term Life Insurance - Senior Citizens Can Qualify for Coverage! 2Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 2Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 3Health News:Phoseon Technology Continues to Drive Growth Worldwide 2Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 2Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 3Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 3
... Breaking news on sexual performance, diabetes, combating obesity, steroid ... a series of news briefings at ENDO 08, the ... Sunday, June 15 , Sexy Sex Findings ... men and women. Topics include erectile dysfunction, boosting womens ...
... a global,provider of products and services that improve the ... of directors has approved a 17,percent increase in the ... regular quarterly dividend is payable on July 15 to ... a 12-cents-per-share quarterly,dividend since July 15, 2007 and has ...
... May 5, 2008/Saranac Lake, N.Y.-- On May 12, 2008, ... stamp in their Distinguished Americans series. The stamp, the ... Trudeau (1848-1915). Stamp collecting is one of the most ... to 20 million American collectors participating in the activity. ...
... http://www.nhs.uk ), the new,digital ,front door, to the ... to,help people stay healthy during their travels abroad., ... Well Travel health guide,( http://www.nhs.uk/livewell/travelhealth/Pages/Travelhealthhome.aspx ),enables users to ... clinically approved guidance to help them stay healthy ...
... May 7 DaVita Inc. (NYSE:,DVA) announced ... an increase to,its current stock repurchase program. ... the repurchase of $250,000,000 of,the Company,s common ... expiration,date., (Logo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO ), ...
... 7 Genzyme Corp.,(Nasdaq: GENZ ) reported ... an,ongoing open-label Phase 2 clinical trial of its ... a meaningful impact,on key clinical manifestations of Gaucher ... to become an innovative treatment option for,Gaucher disease., ...
Cached Medicine News:Health News:ENDO 08 preliminary news conference and webcast schedule 2Health News:Cardinal Health Increases Quarterly Dividend by 17 Percent 2Health News:New United States Postal Service stamp honors an American scientist 2Health News:New United States Postal Service stamp honors an American scientist 3Health News:Preliminary Results from Phase 2 Genzyme Study Highlight Potential of Novel Oral Compound for Gaucher Disease 2Health News:Preliminary Results from Phase 2 Genzyme Study Highlight Potential of Novel Oral Compound for Gaucher Disease 3Health News:Preliminary Results from Phase 2 Genzyme Study Highlight Potential of Novel Oral Compound for Gaucher Disease 4Health News:Preliminary Results from Phase 2 Genzyme Study Highlight Potential of Novel Oral Compound for Gaucher Disease 5
... TRACH CARE Dual Lumen, allows ... the patient end of the ... Swivel Elbow and Direction Tip ... Offers multiple tracheostomy sizes, French ...
... TRACH CARE WET PAK is ... Double Swivel Elbow configurations. Catheters ... vials per catheter. Features lavage/irrigation ... French sizes and packaging configurations. ...
... BALLARD Adult TRACH CARE ... endotracheal intubated patients. Rounded ... provide smooth surface interface. ... locking thumb port. Offers ...
... Our soft, flexible whistle tip suction ... kit that includes: One pair of ... 120 ml bottle of sterile saline. ... use with cuffed gloves and catheter ...
Medicine Products: